
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
The Manual for Electric Vehicles that will be hot dealers in 2023 - 2
Paraplegic engineer becomes the first wheelchair user to blast into space - 3
Instructions to Pick the Ideal SUV Size for Seniors - 4
Paris Agreement target off the table, report says - 5
James Webb Space Telescope spies mysterious high-energy radiation in star nursery
Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
Pick Your Number one sort of blossom
Finding Europe's Head Traveler Objections: An Excursion Through Famous Attractions
From record warming to rusting rivers, 2025 Arctic Report Card shows a region transforming faster than expected
Sixteen Kenyans missing in Russia after army recruitment
Ukrainian man arrested in Germany on suspicion of spying for Russia
Artemis 2 astronauts are about to see one of the rarest skywatching sights of all — a solar eclipse from beyond the moon
What's an atmospheric river? AP explains the weather phenomenon













